Abstract
A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Letters in Drug Design & Discovery
Title: Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity
Volume: 8 Issue: 8
Author(s): Babasaheb P. Bandgar, Baliram S. Hote and Shivraj H Nile
Affiliation:
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Abstract: A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Export Options
About this article
Cite this article as:
P. Bandgar Babasaheb, S. Hote Baliram and Nile Shivraj H, Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576051
DOI https://dx.doi.org/10.2174/157018011796576051 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Current Cancer Therapy Reviews NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Anti-Cancer Agents in Medicinal Chemistry Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Current Medicinal Chemistry Inhibition of Carbonic Anhydrase IX: A New Strategy Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Polyglandular Autoimmune Syndromes
Current Immunology Reviews (Discontinued) Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Current Cancer Drug Targets Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery VEGF and HIF in Renal Cell Carcinogenesis
Recent Patents on Biomarkers Forms of Iron Binding in the Cells and the Chemical Features of Chelation Therapy
Mini-Reviews in Medicinal Chemistry Cancer Preventive Phytochemicals as Speed Breakers in Inflammatory Signaling Involved in Aberrant COX-2 Expression
Current Cancer Drug Targets Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Current Pharmaceutical Design Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
Current Medicinal Chemistry Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents
Recent Patents on Anti-Cancer Drug Discovery Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Current Drug Metabolism Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Current Signal Transduction Therapy Editorial [Hot Topic: Anticancer Macromolecular Prodrugs in Clinical Trials - an Update (Guest Editor: Felix Kratz)]
Current Bioactive Compounds Myelodysplastic/Myeloproliferative Neoplasms
Current Cancer Therapy Reviews Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands
Current Topics in Medicinal Chemistry Emerging Therapeutic Approaches Multi-Targeting Receptor Tyrosine Kinases and G Protein-Coupled Receptors in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry